A Phase II Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Adrenocortical Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Phase II Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Adrenocortical Carcinoma

Published:2018-12 Issue: Volume:232 Page:383-388
ISSN:0022-4804
Container-title:Journal of Surgical Research
language:en
Short-container-title:Journal of Surgical Research

Author:

Hughes Marybeth S.,Lo Winifred M.,Beresnev Tatiana,Merino Maria,Shutack Yvonne,Ripley R. Taylor,Hernandez Jonathan M.,Davis Jeremy L.

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Surgery

Reference23 articles.

1. Combination chemotherapy in advanced adrenocortical carcinoma;Fassnacht;N Engl J Med,2012

2. Current management options for recurrent adrenocortical carcinoma;Glover;Onco Targets Ther,2013

3. Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors;Bilimoria;Cancer,2008

4. Update in adrenocortical carcinoma;Fassnacht;J Clin Endocrinol Metab,2013

5. Adrenocortical carcinoma: the management of metastatic disease;Fay;Crit Rev Oncol Hematol,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated Approach in Locally Advanced, Oligometastatic or Recurrent Adrenocortical Carcinoma;Updates in Surgery;2024-07-25

2. Treatment of recurrent malignant pheochromocytoma with a novel approach: A case report and review of literature;International Journal of Surgery Case Reports;2024-04

3. Intra- and Interpatient Drug Response Heterogeneity Exist in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Nongynecologic Cancers;Annals of Surgical Oncology;2024-01-04

4. Expertise Area 3.3: Adrenal cancer;Rare and Complex Urology;2024

5. Bridging the Scientific Gaps to Identify Effective Treatments in Adrenocortical Cancer;Cancers;2022-10-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3